Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ceftriaxone
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- J01DD04
- Strength
- 250 mg
- Dosage form
- Injection
- Pack
- 1's
- Registration no.
- 061180
- Price record verified
- 2026-08-11
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 181.17 to 186.87 (+3.1%) between 1 Jul 2024 and 1 Jul 2025 · 2 official price records · pack 1's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Dayline 250 mg, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/dayline-250-mg-061180-1s-high-q-pharmaceuticals/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 186.87 | 2025-07-01 | 2026-08-11 | DRAP PharmaPrice Index | Current |
| PKR 181.17 | 2024-07-01 | 2026-08-11 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 061180Price and registration data on this page were observed on 11 August 2026. Records change over time, so please cite the observation date alongside the access date.
